Faculty Disclosures
| Renee Shellhaas, MD |
No disclosure on file
|
| Tobias Loddenkemper, MD, FAAN |
No disclosure on file
|
| Robert E. Hogan, MD |
Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics. |
| Brenda E. Porter, MD, PhD |
An immediate family member of Dr. Porter has received personal compensation for serving as an employee of Sangamo. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. An immediate family member of Dr. Porter has received stock or an ownership interest from Johnson and Johnson. |
| Samuel Tomlinson |
No disclosure on file
|
| Tapan Mehta, MD |
No disclosure on file
|
| Smit D. Patel, MD, MPH |
Dr. Patel has nothing to disclose. |
| Page B. Pennell, MD, FAAN |
The institution of Dr. Pennell has received research support from NIH. Dr. Pennell has received publishing royalties from a publication relating to health care. |
|
No disclosure on file
|
| Thomas K. Tcheng, PhD |
No disclosure on file
|
| Wassim Elyaman, PhD |
Dr. Elyaman has nothing to disclose. |
| Rani A. Sarkis, MD, MSc |
Dr. Sarkis has nothing to disclose. |
| Martha Morrell, MD, FAAN |
Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health. |
| Philip De Jager, MD, PhD |
Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from Biogen. The institution of Dr. De Jager has received research support from puretech. |
| Lindsay Schommer, NP |
No disclosure on file
|
| Cindy Moe |
No disclosure on file
|
| Robert C. Sergott, MD |
Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. |
| W D. Shields, MD |
No disclosure on file
|
| Eric D. Marsh, MD, PhD |
Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape. |
| Barbara C. Jobst, MD, PhD, FAAN |
Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from Harvard Pilgrim. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC. |
| Paul R. Jarvis, MD |
No disclosure on file
|
| Rod Foroozan |
No disclosure on file
|
| Tze-Chiang Meng |
Tze-Chiang Meng has received personal compensation for serving as an employee of Proximagen, LLC. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Abbott Laboratories that is relevant to AAN interests or activities. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Johnson & Johnson that is relevant to AAN interests or activities. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Medtronic that is relevant to AAN interests or activities. Tze-Chiang Meng has a non-compensated relationship as a Stockholder with 3M that is relevant to AAN interests or activities. |
| Salma Sayeed, PharmD |
No disclosure on file
|
| Heidi L. Henninger, MD, FAAN |
Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. |
| Keith J. Nagle, MD |
No disclosure on file
|
| Felicia Chu, MD |
No disclosure on file
|
| Peter Van Ess |
Peter Van Ess has received personal compensation for serving as an employee of Proximagen. |
| Yee-Leng Tan, MBBS |
No disclosure on file
|
| Lindy L. Bancke, PharmD |
No disclosure on file
|
| R E. Faught, Jr., MD, FAAN |
Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. |
| Adam Ziemann, MD, PhD |
Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie. |
| Robert Knowlton, MD |
No disclosure on file
|